Does LEVOMILNACIPRAN Cause Maternal exposure timing unspecified? 8 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Maternal exposure timing unspecified have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 0.6% of all adverse event reports for LEVOMILNACIPRAN.
8
Reports of Maternal exposure timing unspecified with LEVOMILNACIPRAN
0.6%
of all LEVOMILNACIPRAN reports
8
Deaths
8
Hospitalizations
How Dangerous Is Maternal exposure timing unspecified From LEVOMILNACIPRAN?
Of the 8 reports, 8 (100.0%) resulted in death, 8 (100.0%) required hospitalization, and 8 (100.0%) were considered life-threatening.
Is Maternal exposure timing unspecified Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOMILNACIPRAN Cause?
Off label use (376)
Drug ineffective (315)
Gastrooesophageal reflux disease (295)
Vomiting (294)
Hypoaesthesia (290)
Abdominal pain upper (285)
Paraesthesia (282)
Memory impairment (277)
Blepharospasm (276)
Taste disorder (276)
What Other Drugs Cause Maternal exposure timing unspecified?
RITUXIMAB (402)
METHOTREXATE (350)
ADALIMUMAB (343)
DICLOFENAC (331)
TOCILIZUMAB (327)
HYDROXYCHLOROQUINE (309)
FOLIC ACID (304)
INFLIXIMAB (303)
LEFLUNOMIDE (302)
SECUKINUMAB (301)
Which LEVOMILNACIPRAN Alternatives Have Lower Maternal exposure timing unspecified Risk?
LEVOMILNACIPRAN vs LEVONORGESTREL
LEVOMILNACIPRAN vs LEVORPHANOL
LEVOMILNACIPRAN vs LEVOSIMENDAN
LEVOMILNACIPRAN vs LEVOSULPIRIDE
LEVOMILNACIPRAN vs LEVOTHYROXINE